Speaker illustration

Doctor Ana Barat

Novartis Ireland Ltd, Dublin (Ireland)

Clinical characteristics of HFrEF patients with monogenic rare variants in DCM genes: a subgroup analysis of the PARADIGM-HF trial

Event: Heart Failure 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb